Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Ergomed
Ergomed
Activities:
Regulatory
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
Ergomed strongly positioned for future growth in new partnership with Permira
Through this partnership, Permira will support Dr. Miroslav Reljanović and the team in Ergomed’s next phase by accelerating the growth of the business
Research & Development
Ergomed Board and Management changes
Regulatory
Ergomed subsidiary PrimeVigilance enters US market and opens office in Boston, USA
US base gives PrimeVigilance the presence needed to support its current North American clients
Regulatory
Ergomed makes changes to Board of Directors
Neil Clark becomes CEO of PrimeVigilance, while Stephen Stamp is appointed as Chief Financial Officer of Ergomed
Research & Development
Ergomed strengthens management team
Andrew Mackie brings 25 years of industry experience to lead business development at the company
Regulatory
Peter George joins Board of Ergomed as Non-Executive Director
He is currently Chief Executive of Clinigen
Subscribe now